The market has been high on Aileron Therapeutics Inc (ALRN) stock recently. ALRN gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With ALRN Stock Today?
Aileron Therapeutics Inc (ALRN) stock is trading at $1.48 as of 1:22 PM on Thursday, Oct 8, a gain of $0.15, or 11.28% from the previous closing price of $1.33. The stock has traded between $1.33 and $1.50 so far today. Volume today is more active than usual. So far 933,118 shares have traded compared to average volume of 341,256 shares.
More About Aileron Therapeutics Inc
Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing and commercializing a novel class of therapeutics called stapled peptides. The company's lead product candidate, ALRN-6924, targets the tumor suppressor p53 for the treatment of a wide variety of cancers.